http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0204510cb7124dd33a52a34d6cbe38a
Outgoing Links
Predicate | Object |
---|---|
family-name | Nitsche |
name | Andreas Nitsche |
given-name | Andreas |
organization-name | Centre for Biological Security, Robert Koch Institute, Berlin, Germany Robert Koch-Institut, Zentrum für Biologische Sicherheit 1, Berlin, Germany Robert Koch-Institut, Zentrum für Biologische Sicherheit, D-13353 Berlin, Germany Zentrum für Biologische Sicherheit 1, Robert Koch Institut, Nordufer 20, 13353 Berlin, Germany Centre for Biological Threats and Special Pathogens, Robert Koch Institute , Seestrasse 10, Berlin 13353, Germany Medizinische Klinik II m.S. Onkologie und Hämatologie, Charité, Humboldt Universität, 10117 Berlin, Germany Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany Centre for Biological Threats and Special Pathogens (ZBS1), Robert Koch Institute, Berlin, Germany Robert Koch Institute Center for Biological Threats and Special Pathogens 13353 Berlin Germany Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestr. 10, Berlin 13353, Germany Center for Biological Safety, Robert Koch Institute, Berlin, Germany From the Klinikum der Philipps-Universität Marburg, Zentrum Innere Medizin, Abteilung Hämatologie/Onkologie/Immunologie, Marburg, Germany; III. Medizinische Universitätsklinik, Klinikum Mannheim der Universität Heidelberg, Germany; and Klinik für Innere Medizin m.S. Hamatologie und Onkologie, Charité-Campus Virchow Klinikum, Humboldt Universität, Berlin, Germany. Centre for Biological Threats and Special Pathogens 1 – Highly Pathogenic Viruses & German Consultant Laboratory for Poxviruses & WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute , Berlin, Germany Robert Koch-Institut, Berlin, Germany Robert Koch-Institute, Berlin Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1) Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353 Berlin, Germany; Medizinische Klinik II m.S. Onkologie und Hämatologie, Charité, Humboldt Universität, Berlin, Germany. Robert Koch Institute, Centre for Biological Threats and Special Pathogens, ZBS 1: Highly Pathogenic Viruses, Seestr. 10, 13353, Berlin, Germany Klinik für Innere Medizin m.S. Hämatologie und Onkologie, Charité Campus Virchow-Klinikum, Humboldt Universität zu Berlin,2 and Centre for Biological Threats and Special Pathogens Robert Koch Institute Berlin Germany Robert Koch Institut, Nordufer 20, D-13353 Berlin, Germany Robert Koch Institute Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1) Berlin Germany Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany Robert Koch-Institut; ZBS 1 – Highly Pathogenic Viruses; D-13353 Berlin; Germany Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany Robert Koch Institute (RKI), Center for Biological Threats and Special Pathogens, German Reference Laboratory for Poxviruses, Berlin, Germany Robert Koch Institute, Berlin, Germany Robert Koch Institute, Centre for Biological Security, Berlin, Germany Robert Koch Institute, Berlin Centre for Biological Threats and Special Pathogens. Center for Biological Security 1, Robert Koch Institute, Berlin, Germany Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Berlin Klinik für Innere Medizin m.S. Hämatologie und Onkologie, Charité-Campus Virchow Klinikum, Humboldt Universität zu Berlin,1 Highly Pathogenic Viruses (ZBS1), Robert Koch Institute, Berlin, Germany Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS1) Robert Koch Institute Berlin Germany Department of Medicine, Division of Hematology/Oncology, Charité-Virchow-Klinikum, Humboldt University Berlin, Augustenburger Platz 1, 13353 Berlin, Germany; Centre for Biological Security 1, Robert Koch Institute, Berlin, Germany 1 Research Group Bioinformatics (NG4), 2Centre for Biological Threats and Special Pathogens 1 (ZBS 1), 3Centre for Biological Threats and Special Pathogens 6 (ZBS 6) and 4Central Administration 4 (IT), Robert Koch Institute, 13353 Berlin, Germany Center for Biological Safety-Highly Pathogenic Viruses (ZBS1), Robert Koch-Institut, Nordufer 20, 13353 Berlin, Germany Centre for Biological Threats and Special Pathogens Robert Koch Institute Highly Pathogenic Viruses (ZBS 1) Berlin Germany Zentrum für Biologische Sicherheit 1, and Centre for Biological Threats and Special Pathogens: Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353Berlin, Germany Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, World Health Organization (WHO) Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany Med. Klinik II, Charite-Campus Charite Mitte, Berlin, Germany; Robert Koch Institute, Berlin, Germany Klinik für Innere Medizin m.S. Hämatologie und Onkologie, Charité-Campus Virchow Klinikum, Humboldt Universität, Augustenburger Platz 1, Forschungshaus 37 R 2.303, D-13353 Berlin, Germany Robert Koch Institute, Centre for Biological Threats and Special Pathogens 1, Berlin, Germany Medizinische Klinik II, Charité‐Campus Charité Mitte, Humboldt Universität zu Berlin, Germany; Robert Koch‐Institute, Berlin, Germany Centre for Biological Safety 1, Robert Koch Institute, Berlin, Germany |
Incoming Links
Total number of triples: 282.